Next Quarterly Earnings
Wednesday, November 11, 2026
CW 46
Pre-Market
In 76 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Ascendis Pharma ADR
Ascendis Pharma ADR, headquartered in Denmark, is a leading biopharmaceutical company specializing in developing innovative therapies using its proprietary TransCon technology platform. The company focuses on optimizing known active ingredients to address the needs of patients with rare diseases.
Frequently asked questions
When will Ascendis Pharma ADR report its next quarterly earnings?
Ascendis Pharma ADR is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did Ascendis Pharma ADR last report quarterly earnings?
Ascendis Pharma ADR last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at 3.22 USD.
How often has Ascendis Pharma ADR beaten expectations?
Ascendis Pharma ADR has beaten analyst EPS estimates in 2 of its last 3 evaluated quarters (beat rate: 66.7%).
How do I add the Ascendis Pharma ADR earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
2/3
Quarters above estimates
66.7%
Beat rate
+1,935.9%
Avg. EPS surprise
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Ascendis Pharma ADR
Country
🇩🇰
More Financial Information